Moleculin highlights Annamycin's non-cardiotoxic profile in CEO video

Go back to Moleculin highlights Annamycin's non-cardiotoxic profile in CEO video
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.68 +0.03 (4.62%)
Previous Close $0.65    52 Week High $9.58 
Open $0.66    52 Week Low $2.34 
Day High $0.70    P/E N/A 
Day Low $0.64    EPS $-0.34 
Volume 92,830